Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,732Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Zenara Pharma

02 6ANDA Repository

03 1Accord healthcare

04 6Ajanta Pharma Limited

05 6Alembic Pharmaceuticals Limited

06 6Alkem Laboratories

07 6Amneal Pharmaceuticals

08 5Apotex Inc

09 6Aurobindo Pharma Limited

10 15H. Lundbeck AS

11 6Hetero Drugs

12 6Intas Pharmaceuticals

13 6Lupin Ltd

14 6MSN Laboratories

15 6Otsuka Chemical Co Ltd

16 6Otsuka Holdings

17 6Prinston

18 6Sandoz B2B

19 6Teva Pharmaceutical Industries

20 6Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

02

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

11

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

12

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

13

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

14

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

15

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

16

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

17

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

18

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

19

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

20

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank